# Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer

> **NCT00436657** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Peritoneal Neoplasms
- Retroperitoneal Neoplasms
- Gastrointestinal Neoplasms
- Adenocarcinoma
- Neuroblastoma
- Ovarian Neoplasms
- Sarcoma
- Adrenocortical Carcinoma
- Wilms Tumor
- Rhabdomyosarcoma
- Desmoplastic Small Round Cell Tumor

## Interventions

- **DRUG:** CHPP of Cisplatin
- **PROCEDURE:** Abdominal Surgery

## Key facts

- **NCT ID:** NCT00436657
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00436657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00436657, "Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00436657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*